Compare Eli Lilly And Co (LLY) vs Meta Platforms Inc (META) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Meta Platforms Inc — how do they compare? Eli Lilly And Co trades at $1,175.96 (market cap $1.02T), while Meta Platforms Inc trades at $640.51 (market cap $1.64T). The key difference: Meta Platforms Inc is the larger of the two by market cap, and Eli Lilly And Co pays the higher dividend (0.6%). Which is the better fit depends on your goals.
| LLY | META | |
|---|---|---|
Market Cap | $1.02T | $1.64T |
Sector | Health | Media |
52-Week High | $1.24K | $790.00 |
52-Week Low | $625.65 | $525.72 |
Enterprise Value | $1.06T | $1.65T |
Dividend Yield | 0.6% | 0.33% |
Volume | — | 24,093,972 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,175.15, down 0.33% on the day, with a bullish technical signal and strong fundamental momentum. Revenue surged to $65.18B in 2025, with net income reaching $20.64B, and the company has beaten earnings estimates for three consecutive quarters. Recent news includes a lawsuit from Novo Nordisk over weight-loss drug advertising, but analyst sentiment remains overwhelmingly positive with a $1,380 consensus price target.
Outlook is supported by robust earnings growth and high profitability margins, but risks include competitive pressures and elevated valuation multiples. The stock's current price is near key resistance at $1,174, with institutional buying activity indicating continued confidence in Lilly's growth trajectory in the pharmaceutical sector.
Meta Platforms (META) trades at $643.81, down 0.34% on the day, with strong technical momentum showing bullish moving averages and neutral oscillators. The company demonstrates robust fundamentals with 2025 revenue of $201B, net income of $60.5B, and impressive profitability margins including 81.9% gross margin and 32.8% net margin. Recent catalysts include the launch of Muse Spark AI model and consistent earnings beats, with Q1 2026 EPS of $10.44 significantly exceeding expectations of $6.70.
The outlook remains positive with analyst consensus price target of $817.32 representing 27% upside potential. Key opportunities include AI monetization through Muse Spark and strong advertising revenue growth, while risks involve ongoing litigation regarding youth addiction claims and elevated capital expenditures for AI infrastructure. Wall Street maintains strong bullish sentiment with 79% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →
